Recent trends in inhaled corticosteroid prescriptions and its impact on COPD management: an analysis of the KOLD/KOCOSS cohorts

Conclusions: Prescriptions of ICS in COPD patients decreased with increased use of long-acting dual bronchodilators. ICS withdrawal might impact severe exacerbation; therefore it should be decided with consideration of potential risk and benefits of ICS based on patients’ characteristics.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Lee, S. H., Lee, J.-H., Yoon, H. I., Park, H. Y., Kim, T.-H., Yoo, K. H., Oh, Y.-M., Jung, K. S., Lee, S.-D., Lee, S. W. Tags: Airway pharmacology and treatment Source Type: research